Latest News

October 07, 2002
## 15 Seconds: San Francisco General Hospital Medical Center will conduct a clinical trial this fall intended to help patients suffering severe brain damage as a result of accidents or assaults.  The study will involve lowering patien’s body temperature.  For more information, call 415/206-3220. ## 20 Seconds:
October 07, 2002
Neurocirujanos de la Universidad de California en San Francisco están planeando realizar un estudio en el Hospital General de esta ciudad para determinar si bajar la temperatura del cuerpo de los pacientes con lesiones traumáticas del cerebro es eficaz para mejorar el estado de salud de estas personas. 
October 07, 2002
UCSF neurosurgeons at San Francisco General Hospital Medical Center are planning a unique clinical study to see if lowering the body temperature of patients with severe traumatic brain injury (TBI) will help improve their condition - but first the neurosurgeons need to reach the local public, in part through the media.
October 02, 2002
The trouble with most anti-anxiety drugs is that they tend to sedate, not just relax. A research team led by scientists at UCSF’s Ernest Gallo Clinic and Research Center has shown that de-activating a common enzyme in neurons reduces anxiety without inducing sedation. The study in mice suggests a new route to treat anxiety while avoiding sedating and possibly addicting effects. The research, published in the October issue of The Journal of Clinical Investigation, also showed that blocking the enzyme reduced levels of stress hormones.
September 30, 2002
A new study heightens concerns that Cipro and related antibiotics are being over-prescribed, accelerating bacterial resistance to the drugs and reducing their ability to treat infections.
September 30, 2002
UCSF researchers have found that macrophages-literally “big eaters,” normally key immune defense cells that engulf and devour bacteria and tumor cells-when taken from HIV-infected lymphoma patients and injected into mice, induced aggressive mouse T-cell lymphomas in the mice.  Macrophages from healthy donors did not.
September 30, 2002
Maurice Sokolow, MD, a cardiologist and an international expert in hypertension, died Thursday of cancer at UCSF Medical Center in San Francisco.  He was 91 years old. “Sokolow was a pioneer in the field of hypertension, including the effects of stress on blood pressure,” said Lee Goldman, MD, MPH, UCSF chair of the department of medicine and professor of medicine, “and he was a beloved member of the UCSF community since 1936.”
September 30, 2002
With the help of data from the Human Genome Project, UCSF scientists have developed a new technique for screening tumors that highlights the role of a non-genetic mechanism in cancer. The researchers say the approach, which they applied to the study of human brain tumors, “widens the lens” on the cancer genome, and could lead to new therapeutic targets.
September 28, 2002
A new study heightens concerns that Cipro and related broad-spectrum antibiotics known as fluoroquinolones are being over-prescribed, accelerating bacterial resistance to the drugs and reducing their ability to treat infections.
September 27, 2002
There is a growing chasm between the practice of dentistry in the U.S. and the oral health needs of the nation, according to a recent study “The Growing Challenge of Health Care in America” published in the September 5 issue of Health Affairs.

Pages